News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Wall St. Treating Pharmaceutical IPOs Like Plague
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The market for biomedical and pharmaceutical companies going public is sick.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
December 5, 2024
·
2 min read
·
Tristan Manalac
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
December 4, 2024
·
1 min read
·
Kate Goodwin
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
December 4, 2024
·
2 min read
·
Heather McKenzie
Podcast
Biopharma’s Shopping Spree, Applied Crashes on Rejection, Skysona’s Safety Concerns, More
December 4, 2024
·
1 min read
·
Heather McKenzie
